Nucleus, a company whose backers include Peter Thiel and Alexis Ohanian, snaps up David Sloane’s Cambrean to combine genetics insights and real-time health monitoring ...
A new outlook document by Lisney, led by managing director David Byrne, has predicted the rise in distressed asset sales ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback